罕见病与前沿技术论坛

返回主日程
13:30 - 17:00
  • 罕见病与前沿技术论坛
  • Rare Diseases and Advanced Technologies Forum
    • 主持人
  • 张志娟 , 中国医药创新促进会政策研究中心副主任
  • ZHANG Zhijuan , Deputy Director of Policy Research Center of China Pharmaceutical Innovation and Research Development Association (PhIRDA)
13:30 - 13:40
  • 开场致辞
  • Welcome Remarks
  • 李林康 国家卫健委罕见病诊疗与保障专家委员会副主任委员兼办公室主任
  • LI Linkang , Vice Chairman, Expert Committee on Diagnosis, Treatment and Support of Rare Diseases of the National Health Commission
13:40 - 14:10
  • 报告1
  • Keynote Speech 1
  • 中国罕见病药物临床试验趋势
  • Trends in Clinical Trials of Rare Diseases in China
  • 韩晓红 北京协和医院临床药理研究中心主任
  • HAN Xiaohong , Professor, Director, Clinical Pharmacology Research Center,Peking Union Medical College Hospital
14:10 - 14:40
  • 报告2
  • Keynote Speech 2
  • 新型基因编辑工具的开发与应用
  • Development and Application of New Gene Editing Tools
  • 陈佳 上海科技大学基因编辑中心主任
  • CHEN Jia , Director of Gene Editing Center, ShanghaiTech University
14:40 - 15:10
  • 报告3
  • Keynote Speech 3
  • 欧美监管框架和条例对细胞基因治疗发展的影响
  • The Impact of EU/US Regulatory Framework on CGT Development
  • 赵圆 江苏谱新生物医药有限公司首席技术官、欧洲医药监管局(EMA)专家、英国卫生部药品和保健品监督管理局(MHRA)基因治疗部前主任
  • ZHAO Yuan , Chief Technology Officer of Jiangsu Hillgene
15:10 - 15:40
  • 报告4
  • Keynote Speech 4
  • 罕见病药物研发转化新生态
  • New Ecology of Transformation on Rare Diseases Drug R&D
  • 苏明明 武田制药新产品发展部负责人
  • Val SU , Head of New Product Development, Takeda China
15:40 - 16:10
  • 报告5
  • Keynote Speech 5
  • 中国罕见病药物研发的探索与思考
  • China Rare Disease New Drug Development Challenge and Thinking
  • 张苒 北海康成药政事务高级副总裁
  • Rebecca ZHANG , Senior Vice President, Pharmaceutical Affairs, Canbridge Pharma
16:10 - 17:00
  • 讨论
  • Panel
  • 支持罕见病药物“中国新”，我们还需要什么？
  • How to Support China`s Innovative Research and Development in the Field of Rare Diseases
    • 主持人
  • 刘军帅,国家罕见病诊疗与保障专家委员会委员
  • LIU Junshuai, Member of Specialty Committee on Diagnosis, Treatment and Protection of Rare Diseases
    • Panel嘉宾
  • 韩晓红，北京协和医院临床药理研究中心主任
  • HAN Xiaohong，Professor, Director, Clinical Pharmacology Research Center,Peking Union Medical College Hospital
  • 陈佳，上海科技大学基因编辑中心主任
  • CHEN Jia，Director of Gene Editing Center, ShanghaiTech University
  • 张丹，谱新生物联合创始人、联席董事长
  • ZHANG Dan，Co-Founder and Co-Chairman of Jiangsu Hillgene
  • 顾琳慧，武田中国新产品发展部副总监
  • Eileen GU，Associate Director, Takeda China
  • 张苒，北海康成药政事务高级副总裁
  • Rebecca ZHANG，Senior Vice President, Pharmaceutical Affairs, Canbridge Pharma